87 related articles for article (PubMed ID: 1329778)
21. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
24. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
Temma K; Akera T; Brody TM; Rech RH
J Pharmacol Exp Ther; 1983 Sep; 226(3):885-92. PubMed ID: 6887016
[TBL] [Abstract][Full Text] [Related]
25. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
Mirkhani H; Dirin M; Youssef-Zayeh I
Vascul Pharmacol; 2004 Aug; 42(1):23-9. PubMed ID: 15664884
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
28. Naloxone potentiates inotropic but not chronotropic effects of isoproterenol in vitro.
Lechner RB
Circ Shock; 1993 Mar; 39(3):226-30. PubMed ID: 8453747
[TBL] [Abstract][Full Text] [Related]
29. 1,4-Dihydropyridines bearing a pharmacophoric fragment of lidoflazine.
Chiarini A; Rampa A; Budriesi R; Bisi A; Fabbri G; Valenti P
Bioorg Med Chem; 1996 Oct; 4(10):1629-35. PubMed ID: 8931932
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
[TBL] [Abstract][Full Text] [Related]
31. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
[TBL] [Abstract][Full Text] [Related]
32. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
[TBL] [Abstract][Full Text] [Related]
33. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
McCall D
Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
[TBL] [Abstract][Full Text] [Related]
34. Novel quinolizidinyl derivatives as antiarrhythmic agents.
Vazzana I; Budriesi R; Terranova E; Ioan P; Ugenti MP; Tasso B; Chiarini A; Sparatore F
J Med Chem; 2007 Jan; 50(2):334-43. PubMed ID: 17228875
[TBL] [Abstract][Full Text] [Related]
35. [Negative chronotropic and inotropic effects of Panax notoginseng saponins].
Wu JX; Chen JX
Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):409-12. PubMed ID: 3218533
[No Abstract] [Full Text] [Related]
36. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
[TBL] [Abstract][Full Text] [Related]
37. Xanthonolol: a calcium channel and beta-adrenoceptor blocker with vasodilating properties.
Chen IJ; Liou SJ; Liou SS; Lin CN
Gen Pharmacol; 1993 Nov; 24(6):1425-33. PubMed ID: 7906662
[TBL] [Abstract][Full Text] [Related]
38. New benzoxazine and benzothiazine derivatives--structure-activity relations in guinea-pig heart and smooth muscle preparations.
Studenik C; Lemmens-Gruber R; Heistracher P
Pharmazie; 1999 May; 54(5):330-4. PubMed ID: 10368825
[TBL] [Abstract][Full Text] [Related]
39. Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinity.
Hubbard JW; Conway PG; Nordstrom LC; Hartman HB; Lebedinsky Y; O'Malley GJ; Kosley RW
J Pharmacol Exp Ther; 1991 Feb; 256(2):621-7. PubMed ID: 1993999
[TBL] [Abstract][Full Text] [Related]
40. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
